RESPONSE TO MESNA, DOXORUBICIN, IFOSFAMIDE, AND DACARBAZINE IN 108 PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA AND NO PRIOR CHEMOTHERAPY

被引：242
|
作者：
ELIAS, A
RYAN, L
SULKES, A
COLLINS, J
AISNER, J
ANTMAN, KH
机构：
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT,BOSTON,MA 02115
[2] UNIV MARYLAND,CTR CANC,DEPT ONCOL,BALTIMORE,MD 21201
[3] NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 09期
关键词：
D O I：
10.1200/JCO.1989.7.9.1208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1208 / 1216
页数：9
相关论文
共 50 条
  • [41] TREATMENT OF UNRESECTABLE OR METASTATIC OSTEO-SARCOMA WITH CISPLATIN OR CISPLATIN-DOXORUBICIN
    PRATT, CB
    CHAMPION, JE
    SENZER, N
    GREEN, AA
    RAO, B
    DOUGLASS, E
    MEYER, WE
    CROM, DB
    CANCER, 1985, 56 (08) : 1930 - 1933
  • [42] Efficacy, Tolerability and Pharmacokinetic Impact of Aprepitant in Sarcoma Patients Receiving Ifosfamide and Doxorubicin Chemotherapy: A Randomized Controlled Trial
    Xiong, Jie
    Zhao, Guifang
    Yang, Shengli
    Chen, Jing
    ADVANCES IN THERAPY, 2019, 36 (02) : 355 - 364
  • [43] Efficacy, Tolerability and Pharmacokinetic Impact of Aprepitant in Sarcoma Patients Receiving Ifosfamide and Doxorubicin Chemotherapy: A Randomized Controlled Trial
    Jie Xiong
    Guifang Zhao
    Shengli Yang
    Jing Chen
    Advances in Therapy, 2019, 36 : 355 - 364
  • [44] Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females
    Zanetta, G
    Rota, SM
    Lissoni, A
    Chiari, S
    Bratina, G
    Mangioni, C
    BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) : 403 - 406
  • [45] Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females
    G Zanetta
    S M Rota
    A Lissoni
    G Bratina
    C Mangioni
    British Journal of Cancer, 1999, 80 : 403 - 406
  • [46] A Case of Retroperitoneal Synovial Sarcoma in Pregnancy Treated with Antepartum Doxorubicin plus Ifosfamide Chemotherapy
    Sipe, Bradley H.
    Obican, Sarah G.
    Henderson-Jackson, Evita
    Riddle, Nicole D.
    Makanji, Rikesh
    Gonzalez, Ricardo J.
    Brohl, Andrew S.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2021, 2021
  • [47] Ifosfamide and Doxorubicin Combination Chemotherapy for Recurrent Nasopharyngeal Carcinoma Patients
    Dede, Didem Sener
    Aksoy, Sercan
    Cengiz, Mustafa
    Gullu, Ibrahim
    Altundag, Kadri
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 2225 - 2228
  • [48] Ambulatory administration of 5-day infusion ifosfamide + mesna: a pilot study in sarcoma patients
    Romain Coriat
    Olivier Mir
    Sandra Camps
    Stanislas Ropert
    Bertrand Billemont
    Mahaut Leconte
    Frédérique Larousserie
    Philippe Anract
    Jérôme Alexandre
    François Goldwasser
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 491 - 495
  • [49] A PHASE-II TRIAL OF DOSE-ESCALATED DOXORUBICIN AND IFOSFAMIDE MESNA IN PATIENTS WITH MALIGNANT MESOTHELIOMA
    DIRIX, LY
    VANMEERBEECK, J
    SCHRIJVERS, D
    CORTHOUTS, B
    PROVE, A
    VANMARCK, E
    VERMEIRE, P
    VANOOSTEROM, AT
    ANNALS OF ONCOLOGY, 1994, 5 (07) : 653 - 655
  • [50] Ifosfamide Dose-Intensification for Patients With Metastatic Ewing Sarcoma
    Magnan, Heather
    Goodbody, Christine M.
    Riedel, Elyn
    Pratilas, Christine A.
    Wexler, Leonard H.
    Chou, Alexander J.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (04) : 594 - 597
12345